Carafate Suspension
NDC Package 58914-170-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Carafate (sucralfate) suspension is a medication used to treat ulcers in the intestines. This formulation utilizes a suspension delivery system. Marketed by Allergan, Inc., this product is identified by NDC 58914-170 and is authorized under FDA application NDA019183.

Identification & Billing

NDC Package Code
58914-170-60
Package Description
6 CUP, UNIT-DOSE in 1 BOX / 10 mL in 1 CUP, UNIT-DOSE
Product Code
58914-170
11-Digit Billing Format
58914017060
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Carafate
Non-Proprietary Name
Sucralfate
Substance Name
Sucralfate
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SUCRALFATE 1 g/10mL
Pharmacologic Class
Usage Information
This medication is used to treat ulcers in the intestines. Sucralfate forms a coating over ulcers, protecting the area from further injury. This helps ulcers heal more quickly.

Regulatory & Marketing

Labeler Name
Allergan, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA019183
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-16-1993
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (58914-170). Click a package code to view its specific billing and regulatory data.

58914-170-14
420 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58914-170-60 identifies a specific commercial package of 6 cup, unit-dose in 1 box / 10 ml in 1 cup, unit-dose of Carafate, a human prescription drug labeled by Allergan, Inc.. This suspension is formulated for oral use and contains sucralfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Allergan, Inc. on December 16, 1993. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat ulcers in the intestines. Sucralfate forms a coating over ulcers, protecting the area from further injury. This helps ulcers heal more quickly.

How is this Allergan, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58914017060. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58914-170-60
11-Digit CMS (5-4-2)
58914-0170-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.